Cargando…

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study

Introduction: Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) present with a range of symptoms including post-exertional malaise (PEM), orthostatic intolerance, and autonomic dysfunction. Dysfunction of the blood vessel endothelium could be an underlying biological mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sørland, Kari, Sandvik, Miriam Kristine, Rekeland, Ingrid Gurvin, Ribu, Lis, Småstuen, Milada Cvancarova, Mella, Olav, Fluge, Øystein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019750/ https://www.ncbi.nlm.nih.gov/pubmed/33829023 http://dx.doi.org/10.3389/fmed.2021.642710

Ejemplares similares

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
por: Rekeland, Ingrid G., et al.
Publicado: (2022)

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study
por: Rekeland, Ingrid G., et al.
Publicado: (2020)

Endothelial dysfunction in ME/CFS patients
por: Sandvik, Miriam Kristine, et al.
Publicado: (2023)

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
por: Fluge, Øystein, et al.
Publicado: (2015)

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
por: Hoel, Fredrik, et al.
Publicado: (2021)

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Günther, Oliver P., et al.
Publicado: (2018)

Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Lande, Asgeir, et al.
Publicado: (2020)

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
por: Ueland, Marthe, et al.
Publicado: (2022)

Tailored Communication Within Mobile Apps for Diabetes Self-Management: A Systematic Review
por: Holmen, Heidi, et al.
Publicado: (2017)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
por: Fluge, Øystein, et al.
Publicado: (2009)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome
por: Lunde, Sigrid, et al.
Publicado: (2016)

Acceptability of an mHealth App Intervention for Persons With Type 2 Diabetes and its Associations With Initial Self-Management: Randomized Controlled Trial
por: Torbjørnsen, Astrid, et al.
Publicado: (2018)

Associations between menopausal hormone therapy and sleep disturbance in women during the menopausal transition and post-menopause: data from the Norwegian prescription database and the HUNT study
por: Andenæs, Randi, et al.
Publicado: (2020)

Stages of change for physical activity and dietary habits in persons with type 2 diabetes included in a mobile health intervention: the Norwegian study in RENEWING HEALTH
por: Holmen, Heidi, et al.
Publicado: (2016)

The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome
por: Hanson, Maureen R.
Publicado: (2023)

A Low-Intensity Mobile Health Intervention With and Without Health Counseling for Persons With Type 2 Diabetes, Part 1: Baseline and Short-Term Results From a Randomized Controlled Trial in the Norwegian Part of RENEWING HEALTH
por: Torbjørnsen, Astrid, et al.
Publicado: (2014)

A Mobile Health Intervention for Self-Management and Lifestyle Change for Persons With Type 2 Diabetes, Part 2: One-Year Results From the Norwegian Randomized Controlled Trial RENEWING HEALTH
por: Holmen, Heidi, et al.
Publicado: (2014)

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome
por: Mandarano, Alexandra H., et al.
Publicado: (2018)

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Chu, Lily, et al.
Publicado: (2019)

Natural course of chronic fatigue syndrome/myalgic encephalomyelitis in adolescents
por: Norris, Tom, et al.
Publicado: (2017)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption
por: Tölle, Markus, et al.
Publicado: (2020)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
por: Cortes Rivera, Mateo, et al.
Publicado: (2019)

Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Missailidis, Daniel, et al.
Publicado: (2019)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
por: Komaroff, Anthony L., et al.
Publicado: (2021)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
por: Ariza, Maria Eugenia
Publicado: (2021)

Experiences of Living with Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Strassheim, Victoria, et al.
Publicado: (2021)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: When Suffering Is Multiplied
por: Komaroff, Anthony L.
Publicado: (2021)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
por: Gandasegui, Iñigo Murga, et al.
Publicado: (2021)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
por: Deumer, Undine-Sophie, et al.
Publicado: (2021)

Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Chu, Lily, et al.
Publicado: (2021)

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
por: Gravelsina, Sabine, et al.
Publicado: (2022)

Sex differences in post-exercise fatigue and function in myalgic encephalomyelitis/chronic fatigue syndrome
por: Friedberg, Fred, et al.
Publicado: (2023)

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Brenu, Ekua W, et al.
Publicado: (2011)

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
por: Peterson, D., et al.
Publicado: (2015)

Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients
por: Johnston, Samantha C, et al.
Publicado: (2016)

Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
por: Newberry, Fiona, et al.
Publicado: (2018)

Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?
por: Morris, Gerwyn, et al.
Publicado: (2019)

Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
por: Blomberg, Jonas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lqds97datmln7o19op02s3ub39